Cadrenal Therapeutics Inc...

18.67
0.25 (1.36%)
At close: Jan 30, 2025, 11:57 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22
Net Income -8.36M -6.71M
Depreciation & Amortization 1.98K 1.27K
Stock-Based Compensation 710.38K n/a
Other Working Capital 381.89K 202.84K
Other Non-Cash Items 3.97M 4.50M
Deferred Income Tax n/a n/a
Change in Working Capital 144.31K 607.74K
Operating Cash Flow -3.53M -1.20M
Capital Expenditures -3.25K n/a
Acquisitions n/a n/a
Purchase of Investments n/a -2.28K
Sales Maturities Of Investments n/a n/a
Other Investing Acitivies n/a n/a
Investing Cash Flow -3.25K -2.28K
Debt Repayment -250.00K n/a
Common Stock Repurchased n/a n/a
Dividend Paid n/a n/a
Other Financial Acitivies 250.00K n/a
Financial Cash Flow 11.90M 1.24M
Net Cash Flow 8.37M 32.59K
Free Cash Flow -3.53M -1.20M